|Articles|April 1, 2012
- BioPharm International-04-01-2012
- Volume 25
- Issue 4
BioPharm International, April 2012 Issue (PDF)
Optimizing Filtration Strategies
Advertisement
Articles in this issue
over 13 years ago
A Strong Start to 2012over 13 years ago
Pointed Debateover 13 years ago
Optimizing Adjuvant Filtrationover 13 years ago
The Growing Orphan-Drug Paradigmover 13 years ago
Manufacturers Wrestle with Drug Abuse and Critical Shortagesover 13 years ago
Small Changes, System-Wide Impactover 13 years ago
Knowledge Management Implementationover 13 years ago
Ways to Recover Lost Marginsover 13 years ago
Single-Use Redundant FiltrationNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
AI, CRISPR, and mRNA Driving Biotech’s Smartest Decade Yet
2
Conjugation and Regulation Challenges for Advanced Molecules: Part Two of Three with Abzena
3
Top BP Videos of 2025: An Intersection of AI, Innovation, and Compliance
4
FAQ: Understanding Biosimilars, Biobetters, and Interchangeability
5
